MathewRWilliamsMD

Adult Cardiac Surgery, Minimally Invasive Cardiac Surgery, Cardiovascular Surgery

Chief, Adult Cardiac Surgery Director, Heart Valve Program Director, Interventional Cardiology

Dr. Williams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
530 1st Ave
New York, NY 10016
Phone+1 212-263-7185

Fax+1 212-263-2042

New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 2006 - 2006
New York Presbyterian Hospital (Cornell Campus)Fellowship, Thoracic Surgery, 2004 - 2005
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2001 - 2003
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1996 - 2000
Columbia University Vagelos College of Physicians and SurgeonsClass of 1996

PubMed

1 citations
Use and performance of the evolut FX transcatheter aortic valve system.
Tanvir Bajwa, Guilherme F Attizzani, Hemal Gada, Stanley J Chetcuti, Mathew R Williams
Cardiovascular Revascularization Medicine. 2024-10-01
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk Patients.
S Chris Malaisrie, Mayra Guerrero, Charles Davidson, Mathew Williams, Fábio Sândoli de Brito Jr
Circulation. Cardiovascular Interventions. 2024-08-01
2 citations
Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND study.
Mirjam Kessler, Wolfgang Rottbauer, Ralph Stephan von Bardeleben, Carmelo Grasso, Philipp Lurz
European Journal of Heart Failure. 2024-07-01

Journal Articles

Outcomes After Transcatheter Aortic Valve Replacement in Patients with Low Versus High Gradient Severe Aortic Stenosis in the Setting of Preserved Left Ventricular Eje...
Cezar Staniloae, Ricardo Benenstein, Umair Jangda, Muhamed Saric, Mathew R Williams, Daniel McDonald, Alan Vainrib, Robert Donnino, Journal of Interventional Cardiology

Lectures

Optimum Transcatheter Aortic Valve: Global First-in-Human
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
Technology Description and Clinical Data
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
OPTIMUM TAV First-In-Human Results
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019

No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry ShowsDecember 29th, 2022
Good Results for TAVI in Bicuspid Valves, but Questions PersistMarch 8th, 2022
After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be UnlikelyJuly 21st, 2021
Join now to see all